Long Covid Podcast
97 - Harlan Krumholz - Listen Study & Paxlovid Trial
Aug 16, 2023
Dr. Harlan Krumholz, a leading research scientist at Yale and co-lead of the Paxlovid Trial, discusses the Listen Study and Paxlovid Trial, highlighting the challenges faced by long COVID patients in healthcare. The conversation also delves into the potential of Paxlovid in treating COVID, the patient-centric approach of research studies, and the importance of involving patients in research despite conflicts and challenges.
43:15
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The Paxlovid Trial utilizes a participant-friendly design, allowing individuals to participate from home and removing barriers such as travel and time constraints for investigating the potential of Paxlovid in treating long COVID.
- The podcast emphasizes the shift towards patient-centered care, highlighting the importance of improving accountability, effectiveness, efficiency, and patient-centeredness in healthcare delivery to address the needs and experiences of those with long COVID.
Deep dives
The Long COVID Podcast: A Digital, Decentralized, and Participant-centric Study
The Long COVID podcast explores the concept of conducting research through a digital, decentralized, and participant-centric approach. The host, Jackie Baxter, interviews Harlan Cromholt, a cardiologist and leading research scientist at Yale. They discuss the development of the Yale PaxLovid trial, which aims to investigate the potential of PaxLovid, an oral antiviral pill, in treating long COVID. The trial follows a participant-friendly design, allowing individuals to participate from home and eliminating barriers such as travel and time constraints. The goal is to create a model that is efficient, inclusive, and responsive to the needs and experiences of those with long COVID.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
